Diabetes in Pregnancy Clinical Trial
Official title:
Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes
Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - All pregnant women presented at the delivery ward in Sohag University Hospital, Sohag, Egypt with the following criteria: 1. Study group: Singleton pregnancies complicated with diabetes undergoing pre-labour CS at gestational age (37+0 to 40+0). These will be divided into 3 groups according to the type of disease either Gestational diabetes (Group A), pregestational diabetes type 1 (Group B) or type 2 (Group C). 2-Control group: Singleton pregnancies undergoing elective pre-labour CS at gestational age (37+0 to 40+0) that are otherwise healthy Exclusion Criteria: - Women with history of medical co-morbidities other than diabetes are excluded from the study. This includes the following: Chronic hypertension, renal diseases, autoimmune diseases, history of organ transplantation and immunosuppressive therapy, hematological diseases, history of thrombotic events, cardiopulmonary diseases, liver diseases Acute and chronic inflammatory diseases. - Pregnancy induced medical disorders like: Gestational hypertension, preeclampsia, Gestational thrombocytopenia, and proteinuria. - Multiple pregnancies. - Abnormal placentation, i.e. Placenta previa and Morbidly adherent placenta. - Fetal anomalies. - vaginal deliveries and CS in labor. - Spontaneous delivery. |
Country | Name | City | State |
---|---|---|---|
Egypt | Sohag Faculty of Medicine | Sohag |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Egypt,
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018 Feb;131(2):e49-e64. doi: 10.1097/AOG.0000000000002501. — View Citation
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol. 2018 Dec;132(6):e228-e248. doi: 10.1097/AOG.0000000000002960. — View Citation
Blanco MV, Vega HR, Giuliano R, Grana DR, Azzato F, Lerman J, Milei J. Histomorphometry of umbilical cord blood vessels in preeclampsia. J Clin Hypertens (Greenwich). 2011 Jan;13(1):30-4. doi: 10.1111/j.1751-7176.2010.00384.x. Epub 2010 Nov 4. — View Citation
Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016 Apr 19;164(8):542-52. doi: 10.7326/M15-3016. Epub 2016 Mar 1. — View Citation
Diabetes Canada Clinical Practice Guidelines Expert Committee, Feig DS, Berger H, Donovan L, Godbout A, Kader T, Keely E, Sanghera R. Diabetes and Pregnancy. Can J Diabetes. 2018 Apr;42 Suppl 1:S255-S282. doi: 10.1016/j.jcjd.2017.10.038. Erratum in: Can J Diabetes. 2018 Jun;42(3):337. — View Citation
Feig DS, Razzaq A, Sykora K, Hux JE, Anderson GM. Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996-2001. Diabetes Care. 2006 Feb;29(2):232-5. Erratum in: Diabetes Care. 2006 Jul;29(7):1723. — View Citation
Nizyaeva NV, Sukhacheva TV, Serov RA, Kulikova GV, Nagovitsyna MN, Kan NE, Tyutyunnik VL, Pavlovich SV, Poltavtseva RA, Yarotskaya EL, Shchegolev AI, Sukhikh GT. Ultrastructural and Immunohistochemical Features of Telocytes in Placental Villi in Preeclampsia. Sci Rep. 2018 Feb 22;8(1):3453. doi: 10.1038/s41598-018-21492-w. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Telocytes | number of telocytes per high power field detected by IHC | Telocytes will be assessed in placental and umbilical cord tissues fixed immediately after delivery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02968628 -
Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
|
||
Enrolling by invitation |
NCT04129190 -
Single Non-fasting OGTT Versus Fasting OGTT for Screening of Hyperglycaemia in Pregnancy (HIP)
|
Phase 2 | |
Active, not recruiting |
NCT05344066 -
Manchester Intermittent Diet in Gestational Diabetes Acceptability Study
|
N/A | |
Recruiting |
NCT01758016 -
Haptoglobin and Diabetes Complications in Pregnancy
|
N/A | |
Active, not recruiting |
NCT03338829 -
Incentives and Glucose Adherence in Diabetes
|
N/A | |
Not yet recruiting |
NCT06355154 -
Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
|
N/A | |
Completed |
NCT03028506 -
Meal Composition and the Influence on Pre-prandial Blood Glucose Values
|
N/A | |
Completed |
NCT01973374 -
Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy
|
N/A | |
Recruiting |
NCT06319560 -
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
|
N/A |